Myalgic Encephalomyelitis - A Disease Looking for Respect

RDR Staff
Published Online: Tuesday, Mar 05, 2013

Myalgic encephalomyelitis (ME) is a condition with unknown origin and unclear treatment options. Widespread inflammation and multisystemic neuropathology seem to be at the core of its pathophysiology.

ME is also commonly referred to as chronic fatigue syndrome but advocates for the condition prefer the ME nomenclature. Chronic fatigue syndrome has been often misused and/or over-diagnosed in the past so it is currently unclear if ME is a rare condition. A recent prevalence study (Vincent et al 2012)  had the estimated number of patients in the U.S. at around the 200,000 mark but more studies are needed to ascertain its true prevalence.

In this interview with Rare Disease Report, patient - and patient advocate - Charlotte von Salis describes ME and the need for more awareness and funding for this condition.

For more information about this ME, visit www.name-us.org

Reference

Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted Country, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clinic Proc.2012; 87(12):1145-52

Related Articles
All eligible applicants may apply for a maximum grant of $25,000.
“Pride, teamwork, friendship, treating everyone with dignity, giving everyone a chance—that is what the Special Olympics is all about”, said President Obama in a video broadcast during the opening ceremonies of the Special Olympics World Games 2015 in Los Angeles California Saturday night.
Elizabeth M. Wilson of the American Brain Tumor Association (ABTA) talks about a current study the ABTA is funding with other organizations worldwide to learn more about the physiology of survivors of glioblastoma multiforme that allow them to be survivors.
The first set of 2015 research grants by The Cystinosis Research Foundation were recently announced that will provide researchers with a total of $1,022,879.
External Resources

MJH Associates
AJMC
Cure
MD Magazine
OncLive
Pharmacy Times
Specialty Pharmacy Times
Physicians' Education Resource
Internal Resources

Medicine
Advocacy
Business/Regulatory
Events
Conferences
Connect With Us:

About Us
Advertise
Careers
Contact Us
Privacy Policy
Sponsor
Terms and Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Rare Disease Report 2015
Intellisphere, LLC. All Rights Reserved.